NEW YORK March 13 2017 PRNewswire Immune Pharmaceuticals Inc. Nasdaq IMNP "Immune" or the "Company" announced today that following a hearing on March 9 2017 where the Company presented its plan to regain compliance including ongoing bu...
↧